Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement ...

AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market.

To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

Behavioral health was once dismissed as secondary: unseen, underfunded, and misunderstood. Not anymore. Its stigma has faded, and the financial cost of neglecting it is too steep to ignore.

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, permitting longer dosing intervals. Lilly plans to apply the technology to ...

When Covid-19 vaccines roll out for the fall and winter respiratory illness season, they will continue to be based on the same lineage that is the basis for vaccines from this past season, but ...

Gaining greater insight into the patient journey from diagnosis through treatment is a priority for drug developers as they seek to produce more effective drugs. Using non-small cell lung cancer ...